Company name: Oceanic ReLeaf
Description: Manufacturer of pharmaceutical drugs and related products. The company’s product include cannabis drugs cultivated on a land covering an area of 63,000 sq. ft.
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
State: Newfoundland and Labrador
Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Privately Held (no backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: Hiku Brands Company (OTCMKTS: DJACF) reached a definitive agreement to acquire 25% stake in the company for CAD 3 million on March 31, 2018.
Number of active investors:
Profile last updated: 19-Sep-2018
Last known valuation: 9.29
Last known valuation date: 31-Mar-2018